Can you just -- in coming quarters, very generally talk about sort of what is your first plan of attack as we look for the next couple of quarters on the derisking strategy there?

Source: https://seekingalpha.com/article/4642220-berkshire-hills-bancorp-inc-bhlb-q3-2023-earnings-call-transcript?source=feed_all_articles

One thing I like about the phase 3 REACH study (started in Q2 2022) is that from a regulatory standpoint there is a degree of derisking as the FDA agreed to using RWS (absolute change from baseline) as the primary endpoint.

Source: https://seekingalpha.com/article/4607098-fulcrum-therapeutics-fshd-steadily-advancing-in-phase-3-optionality-with-scd?source=feed_all_articles

“We will also be exploring opportunities of derisking our financial institutions in the current financial landscape and looking to bringing fairness to global financial systems towards a world with less poverty and less inequality.”

Source: https://www.citizen.co.za/news/brics-summit-not-get-out-of-jail-free-card-june-2023/